Fused thiophene compounds
AssigneeBioTheryX, Inc.
InventorsKyle W.H. Chan, Aparajita Hoskote Chourasia, Paul E. Erdman, Leah M. Fung, Frank Mercurio, Robert W. Sullivan
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds that modulate protein function, to restore protein homeostasis, and cell-cell adhesion. The disclosure provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of diseases, disorders, or conditions associated with a protein, are provided.
Claims42
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- Q1, Q2, and Q3, are independently CR1, CR2, or —S—;
- wherein one of Q1, Q2, and Q3 is —S—;
- one of Q1, Q2, and Q3 is CR1;
- and one of Q1, Q2, and Q3 is CR2;
- each - - - is a carbon-carbon single bond, a carbon-carbon double bond, or a carbon-sulfur single bond;
- R1 is H, deuterium, hydroxyl, halogen, cyano, nitro, optionally substituted C1-C6 alkoxy, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C1-C6 haloalkoxy, optionally substituted amino, C1-C6 alkylamino, amino(C1-C6 alkyl), (C1-C6 alkoxy)C1-C6 alkyl, —O—(C1-C6 alkoxy)C1-C6 alkyl, or optionally substituted C3-C8 carbocyclyl;
- R2 is
- R3 is H, deuterium, an optionally substituted C1-C6 alkyl,
- X is C═O, CHR4A, or CR4AR4B;
- each R4A and R4B is independently H, deuterium, or C1-C6 alkyl;
- X1 is H, deuterium, fluoro, or C1-C6 alkyl;
- each of XA, XB, and XC is independently a bond, (CH2)m, (CF2)m, O, S, and NH;
- wherein none of XA—XB, XA—XC, or XB—XC is a bond selected from N—N, N—O, N—S, O—N, S—N, O—O, S—S, or N═N;
- wherein, not more than one of XA, XB, and XC can be a bond;
- and wherein any hydrogen of the (CH2)m and NH groups can be substituted by one or more R5;
- R5 is hydrogen, deuterium, halogen, C1-C6 alkyl, or C1-C6 haloalkyl;
- m is 1, 2, or 3;
- n is 0, 1, or 2;
- R6 is C6-C10 aryl, 5 to 10 membered heteroaryl, C3 to C8 carbocyclyl, or 3 to 10 membered heterocyclyl, each optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxyl, optionally substituted C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, (C1-C6 alkoxy)C1-C6 alkyl, —O—(C1-C6 alkoxy)C1-C6 alkyl, C1-C6 alkylamino, amino(C1-C6 alkyl), —C(═O)NR16aR16b, optionally substituted C3-C7 cycloalkyl, optionally substituted C3-C7 cycloalkyl(C1-C6 alkyl), optionally substituted C6-C10 aryl, optionally substituted C6-C10 aryl(C1-C6 alkyl), optionally substituted 5 to 10 membered heteroaryl, optionally substituted 5 to 10 membered heteroaryl(C1-C6 alkyl), optionally substituted heterocyclyl, and optionally substituted heterocyclyl(C1-C6 alkyl);
- each R16a and R16b is independently H or C1-C6 alkyl, or R16a and R16b together with the nitrogen atom to which they are attached form 5 or 6 membered heterocyclyl optionally substituted with one or more R9;
- each R9 is independently C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, (C1-C6 alkoxy)C1-C6 alkyl, —O—(C1-C6 alkoxy)C1-C6 alkyl, optionally substituted amino, halogen, or cyano;
- or two geminal R9 form oxo (═O);
- and
- each of R10, R11, R12, R13, R14, and R15 is independently H, an optionally substituted C1-C6 alkyl, or C3-C6 cycloalkyl;
- or R14 and R15 together with the nitrogen atom to which they are attached form an optionally substituted 5 or 6 membered heterocyclyl.
Dependencies are inferred from the claim text.